Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.

Name: Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.
Author: Takemoto, Shinnosuke

Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA. — المؤلف: Takemoto, Shinnosuke — Thoracic cancer 20200304

المؤلف: Takemoto, Shinnosuke
النشر: Thoracic cancer 20200304
الوصف: 452-458 p.
الموضوعات: Adult؛ Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Bevacizumab؛ Biomarkers, Tumor؛ Carcinoma, Non-Small-Cell Lung؛ DNA-Binding Proteins؛ Disease-Free Survival